Want to join the conversation?
Pharma company $AGN said it has acquired Topokine Therapeutics, a clinical-stage biotech company which develops topical fat reduction medicines. Topokine was acquired for an upfront payment of $85MM and success-based development and sales milestones for XAF5, a topical agent in late-stage development for treating steatoblepharon, or undereye bags.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!